CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Current Assets:
Cash and cash equivalents	$ 194	$ 591
Trade receivables, net of allowance for doubtful accounts of nil and $2 at September 30, 2024 and December 31, 2023, respectively.	2	7
Inventory, net of reserves of $818 at September 30, 2024 and December 31, 2023	636	632
Other current assets	211	163
Total current assets	1,043	1,393
Non-Current Assets:
Property and equipment, net	25	32
Operating lease right-of-use assets, net of amortization	164	227
Other assets	17	17
Total non-current assets	206	276
TOTAL ASSETS	1,249	1,669
Current Liabilities:
Accounts payable	2,100	1,991
Accounts payable, related parties	32	32
Accrued liabilities	923	1,068
Deferred revenue	748	424
Current portion of lease liability	102	91
Short-term notes payable due to related parties	68	0
Current portion of long-term debt, related parties	525	39
Short-term notes payable	228	59
Short-term convertible debt	149	1,105
Short-term convertible debt in default	1,130	0
Derivative liability at fair value	20	0
Total current liabilities	6,025	4,809
Long-Term Liabilities, Net of Current Portion
Long-term lease liability	76	155
Long-term notes payable	53	0
Long-term debt, related parties	13	511
Total long-term liabilities	142	666
Total liabilities	6,167	5,475
STOCKHOLDERS' DEFICIT:
Common stock, $.001 par value; 500,000 shares authorized, 60,457 and 54,105 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively.	3,446	3,441
Additional paid-in capital	141,757	140,983
Treasury stock at cost	(132)	(132)
Accumulated deficit	(153,009)	(151,118)
Total stockholders' deficit	(4,918)	(3,806)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	1,249	1,669
Series C Convertible Preferred Shares [Member]
STOCKHOLDERS' DEFICIT:
Preferred stock, value	105	105
Series C1 Convertible Preferred Shares [Member]
STOCKHOLDERS' DEFICIT:
Preferred stock, value	170	170
Series C2 Convertible Preferred Shares [Member]
STOCKHOLDERS' DEFICIT:
Preferred stock, value	439	439
Series F-2 Convertible Preferred Shares [Member]
STOCKHOLDERS' DEFICIT:
Preferred stock, value	475	475
Series D Convertible Preferred Shares
STOCKHOLDERS' DEFICIT:
Preferred stock, value	159	159
Series E Convertible Preferred Shares
STOCKHOLDERS' DEFICIT:
Preferred stock, value	834	834
Series F Convertible Preferred Shares
STOCKHOLDERS' DEFICIT:
Preferred stock, value	$ 838	$ 838

GUIDED THERAPEUTICS INC 10-Q